Related Experiment Video
Updated: Feb 12, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case
Ryota Matsuki1, Masanori Sugiyama2, Hidefumi Takei3
1Department of Surgery, School of Medicine, Kyorin University, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan. rmatsuki@ks.kyorin-u.ac.jp.
Background:
Long-term survival after resection of metastases from pancreatic ductal adenocarcinoma is rare.
Case Presentation:
A 54-year-old man underwent pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC) with UICC staging pT3N1M0 followed by adjuvant chemotherapy with gemcitabine (GEM). Three years after radical resection of the primary tumor, a tiny nodule was found in the lower lobe of the left lung. Despite treatment with GEM, it increased gradually, but no other metastases were found. Eighteen months after the first indication of the nodule, wedge resection was performed. Pathological examination of the nodule indicated a metastatic tumor from PDAC. Pulmonary metastasectomy was again performed for lung oligometastases at 77 and 101 months after PD. The patient has been asymptomatic without tumor recurrence for 4 years since the last pulmonary resection.
Conclusions:
In PDAC, the treatment strategy for oligometastasis is controversial. However, a few cases of long-term survival after pulmonary metastasectomy for oligometastasis of PDAC have been reported. More such cases need to be studied to address this issue effectively.
Related Concept Videos
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree
Building a Survival Tree
Constructing a...
Long-term Depression
Lung Capacity
Data Reporting and Recording
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...

